Metraipolis › archive › dc_01dba1395141

Case Report: Niraparib-abiraterone in HRR-mutated metastatic castration-resistant prostate cancer: clinical insights from five cases — Europe PMC PMID:42125687

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42125687
DOI
10.3389/fonc.2026.1799304
License (as archived)
solo-consultazione
Archived
2026-11-03T04:12:25.878Z
SHA-256 of the archived text
31ba0783088ef8313edb034e0602662de087ec23683942207dd39ef202ec8cda
Stable URL of this page
https://metraipolis.com/documento/dc_01dba1395141

How to cite

Case Report: Niraparib-abiraterone in HRR-mutated metastatic castration-resistant prostate cancer: clinical insights from five cases — Europe PMC PMID:42125687 — Europe PMC (en), https://europepmc.org/article/MED/42125687 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_01dba1395141 (Metraipolis archive dc_01dba1395141, sha256 31ba0783088ef8313edb034e0602662de087ec23683942207dd39ef202ec8cda)
BibTeX
@misc{dc01dba1395141,
  title = {Case Report: Niraparib-abiraterone in HRR-mutated metastatic castration-resistant prostate cancer: clinical insights from five cases — Europe PMC PMID:42125687},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42125687},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_01dba1395141; sha256 31ba0783088ef8313edb034e0602662de087ec23683942207dd39ef202ec8cda},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42125687. Agents can read the archived copy with the MCP tool read_document.